University of Colorado Hospital

Denver, Colorado 80262

2 studies enrolling now · 33 studies all time

What they study most

Acute Kidney Injury, Acute Myocardial Infarction, Aortic Stenosis, Breast Cancer, Burn-Out Syndrome, Calcific Aortic Stenosis, Cancer, Cannabis Use, Cardiac Transplant, Cardiomyopathies, Cardiomyopathy, Hypertrophic, Chronic Hepatitis C

Studies at this site

• Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine — Recruiting now
• Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey — Recruiting now
• Intra-operative Pancreatoscopy in Patients With IPMN — Running, not enrolling
• Testing the Engaged Approach to Lung Cancer Screening — Running, not enrolling
• Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR — Completed
• Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes — Completed
• LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate — Completed
• Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk — Completed
• Dynamic Coronary Roadmap for Contrast Reduction — Completed
• Pilot Study of High Risk Lung Cancer Screening — Completed
• Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart — Completed
• Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS — Status unconfirmed
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
• Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD) — Withdrawn before enrolling
• Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy — Completed
• Anti-PD-1 +/- RT for MSI-H Solid Tumors — Withdrawn before enrolling
• Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury — Stopped early
• Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7 — Completed
• PARTNER II Trial: S3iCAP — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve — Completed
• Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria — Completed
• A Mindfulness Based Cognitive Therapy (MBCT) Resiliency Program for Critical Care Nurses — Completed
• Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS — Stopped early
• The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B — Completed
• A Phase 1 Study of S-3304 in Patients With Solid Tumors — Completed
• Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide — Stopped early
• Protein and Ultrasound Indicators of Preterm Birth — Completed
• Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C — Completed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
• SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism — Completed